Vertebrate paralogous MEF2 genes: Origin, conservation, and evolution

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Wu, Wenwu ^a   de Folter, Stefan ^b   Shen, Xia ^c   Zhang, Wenqian ^a   Tao, Shiheng ^a  

^a NORTHWEST A F UNIVERSITY   (China)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c SHAANXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; MYOCYTE ENHANCER FACTOR 2B; MYOCYTE ENHANCER FACTOR 2C; MYOCYTE ENHANCER FACTOR 2D; UNCLASSIFIED DRUG; MADS DOMAIN PROTEIN; MYOCYTE SPECIFIC ENHANCER BINDING FACTOR 2; MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR 2; MYOGENIC FACTOR;

AMINO ACID SUBSTITUTION; ARTICLE; GENE DUPLICATION; GENETIC CONSERVATION; GENETIC SELECTION; HUMAN; MEF2A GENE; MEF2B GENE; MEF2C GENE; MEF2D GENE; NONHUMAN; PAN TROGLODYTES; PARALOGY; PHYLOGENY; REGULATOR GENE; SPECIES DIFFERENCE; VERTEBRATE; XENOPUS LAEVIS; ZEBRA FISH; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; GENOME; MOLECULAR EVOLUTION; MOUSE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY;

ANIMALIA; VERTEBRATA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; GENOME; MADS DOMAIN PROTEINS; MICE; MODELS, GENETIC; MYOGENIC REGULATORY FACTORS; OPEN READING FRAMES; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; SELECTION, GENETIC; SEQUENCE HOMOLOGY, AMINO ACID; VERTEBRATES;

EID: 79952356997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017334     Document Type: Article

References (81)

1. Martin JF, Miano JM, Hustad CM, Copeland NG, Jenkins NA, et al. (1994) A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol Cell Biol 14: 1647-1656.
2. Black BL, Olson EN, (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14: 167-196.
3. Zhu B, Gulick T, (2004) Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Molecular and cellular biology 24: 8264.
4. Zhu B, Ramachandran B, Gulick T, (2005) Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. Journal of Biological Chemistry 280: 28749.
5. Martin JF, Schwarz JJ, Olson EN, (1993) Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A 90: 5282-5286.
6. Hobson GM, Krahe R, Garcia E, Siciliano MJ, Funanage VL, (1995) Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23. Genomics 29: 704-711.
7. Pollock R, Treisman R, (1991) Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev 5: 2327-2341.
8. Andres V, Cervera M, Mahdavi V, (1995) Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J Biol Chem 270: 23246-23249.
9. Molkentin JD, Black BL, Martin JF, Olson EN, (1996) Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol Cell Biol 16: 2627-2636.
10. McKinsey TA, Zhang CL, Olson EN, (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27: 40-47.
11. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, et al. (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. The EMBO journal 16: 7054.
12. Yan C, Takahashi M, Okuda M, Lee JD, Berk BC, (1999) Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Journal of Biological Chemistry 274: 143.
13. Nadruz W Jr, Kobarg CB, Constancio SS, Corat P, Franchini KG, (2003) Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2. Circulation research 92: 243.
14. Edmondson DG, Lyons GE, Martin JF, Olson EN, (1994) Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120: 1251.
15. Potthoff MJ, Olson EN, (2007) MEF2: a central regulator of diverse developmental programs. Development 134: 4131-4140.
16. Black BL, Cripps RM, (2010) Myocyte enhancer factor-2 transcription factors in heart development and disease. In: Nadia R, Richard PH, editors. Heart Development and regeneration San Diego Academic Press pp. 673-699.
17. Molkentin JD, Black BL, Martin JF, Olson EN, (1995) Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136.
18. Ornatsky OI, Andreucci JJ, McDermott JC, (1997) A dominant-negative form of transcription factor MEF2 inhibits myogenesis. Journal of Biological Chemistry 272: 33271.
19. Cripps RM, Zhao B, Olson EN, (1999) Transcription of the myogenic regulatory gene Mef2 in cardiac, somatic, and visceral muscle cell lineages is regulated by a Tinman-dependent core enhancer. Developmental biology 215: 420-430.
20. Andres V, Fisher S, Wearsch P, Walsh K, (1995) Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2. Molecular and cellular biology 15: 4272.
21. Vanpoucke G, Goossens S, De Craene B, Gilbert B, Van Roy F, et al. (2004) GATA-4 and MEF2C transcription factors control the tissue-specific expression of the {alpha} T-catenin gene CTNNA3. Nucleic acids research 32: 4155.
22. Morin S, Charron F, Robitaille L, Nemer M, (2000) GATA-dependent recruitment of MEF2 proteins to target promoters. The EMBO Journal 19: 2046-2055.
23. Shalizi AK, Bonni A, (2005) brawn for brains: the role of MEF2 proteins in the developing nervous system. Curr Top Dev Biol 69: 239-266.
24. Choi DW, (1994) Calcium and excitotoxic neuronal injury. Annals of the New York Academy of Sciences 747: 162-171.
25. Rao S, Karray S, Gackstetter ER, Koshland ME, (1998) Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. Journal of Biological Chemistry 273: 26123.
26. Wallin JJ, Rinkenberger JL, Rao S, Gackstetter ER, Koshland ME, et al. (1999) B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development. Journal of Biological Chemistry 274: 15959.
27. Sharma G, Goalstone ML, (2005) Dominant negative FTase (DNFT [alpha]) inhibits ERK5, MEF2C and CREB activation in adipogenesis. Molecular and cellular endocrinology 245: 93-104.
28. Hosking BM, Wang SC, Chen SL, Penning S, Koopman P, et al. (2001) SOX18 directly interacts with MEF2C in endothelial cells. Biochemical and Biophysical Research Communications 287: 493-500.
29. Lin Q, Lu J, Yanagisawa H, Webb R, Lyons GE, et al. (1998) Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125: 4565.
30. Arnold MA, Kim Y, Czubryt MP, Phan D, McAnally J, et al. (2007) MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Developmental Cell 12: 377-389.
31. Verzi MP, Agarwal P, Brown C, McCulley DJ, Schwarz JJ, et al. (2007) The transcription factor MEF2C is required for craniofacial development. Developmental cell 12: 645-652.
32. Nowakowska BA, Obersztyn E, Szymanska K, Bekiesinska-Figatowska M, Xia Z, et al. (2010) Severe Mental Retardation, Seizures, and Hypotonia Due to Deletions of MEF2C. Am J Med Genet B Neuropsychiatr Genet 153B: 1042-1051.
33. Sablowski R, (2010) Genes and functions controlled by floral organ identity genes. Semin Cell Dev Biol 21: 94-99.
34. Alvarez-Buylla ER, Azpeitia E, Barrio R, Benitez M, Padilla-Longoria P, (2010) From ABC genes to regulatory networks, epigenetic landscapes and flower morphogenesis: making biological sense of theoretical approaches. Semin Cell Dev Biol 21: 108-117.
35. Litt A, Kramer EM, (2010) The ABC model and the diversification of floral organ identity. Semin Cell Dev Biol 21: 129-137.
36. Vision TJ, Brown DG, Tanksley SD, (2000) The origins of genomic duplications in Arabidopsis. Science 290: 2114.
37. De Bodt S, Raes J, Florquin K, Rombauts S, Rouze P, et al. (2003) Genomewide structural annotation and evolutionary analysis of the type I MADS-box genes in plants. J Mol Evol 56: 573-586.
38. Parenicova L, De Folter S, Kieffer M, Horner DS, Favalli C, et al. (2003) Molecular and phylogenetic analyses of the complete MADS-box transcription factor family in Arabidopsis: new openings to the MADS world. Plant Cell 15: 1538-1551.
39. Shan H, Zahn L, Guindon S, Wall PK, Kong H, et al. (2009) Evolution of plant MADS box transcription factors: evidence for shifts in selection associated with early angiosperm diversification and concerted gene duplications. Mol Biol Evol 26: 2229-2244.
40. Jimenez S, Lawton-Rauh AL, Reighard GL, Abbott AG, Bielenberg DG, (2009) Phylogenetic analysis and molecular evolution of the dormancy associated MADS-box genes from peach. BMC Plant Biol 9: 81.
41. Hernandez-Hernandez T, Martinez-Castilla LP, Alvarez-Buylla ER, (2007) Functional diversification of B MADS-box homeotic regulators of flower development: Adaptive evolution in protein-protein interaction domains after major gene duplication events. Mol Biol Evol 24: 465-481.
42. Martinez-Castilla LP, Alvarez-Buylla ER, (2003) Adaptive evolution in the Arabidopsis MADS-box gene family inferred from its complete resolved phylogeny. Proc Natl Acad Sci U S A 100: 13407-13412.
43. Santelli E, Richmond TJ, (2000) Crystal structure of MEF2A core bound to DNA at 1.5 A resolution. J Mol Biol 297: 437-449.
44. Huang K, Louis JM, Donaldson L, Lim FL, Sharrocks AD, et al. (2000) Solution structure of the MEF2A-DNA complex: structural basis for the modulation of DNA bending and specificity by MADS-box transcription factors. EMBO J 19: 2615-2628.
45. Brand NJ, (1997) Myocyte enhancer factor 2 (MEF2). Int J Biochem Cell Biol 29: 1467-1470.
46. Wu WW, Huang XT, Cheng J, Li ZG, Stefan DF, et al. (2011) Conservation and evolution in and among SRF- and MEF2-type MADS domains and their binding sites. Mol Biol Evol 28: 501-511.
47. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
48. Huelsenbeck JP, Ronquist F, (2001) MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17: 754-755.
49. Sonnhammer E, Koonin EV, (2002) Orthology, paralogy and proposed classification for paralog subtypes. Trends in Genetics 18: 619-620.
50. Hurst LD, (2002) The Ka/Ks ratio: diagnosing the form of sequence evolution. Trends Genet 18: 486.
51. Bielawski JP, Yang Z, (2005) Maximum likelihood methods for detecting adaptive protein evolution. Statistical Methods in Molecular Evolution pp. 103-124.
52. Yang Z, (1998) Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Molecular Biology and Evolution 15: 568.
53. Yang Z, (2007) PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24: 1586-1591.
54. Alvarez-Buylla ER, Pelaz S, Liljegren SJ, Gold SE, Burgeff C, et al. (2000) An ancestral MADS-box gene duplication occurred before the divergence of plants and animals. Proc Natl Acad Sci USA 97: 5328-5333.
55. Nam J, Kim J, Lee S, An G, Ma H, et al. (2004) Type I MADS-box genes have experienced faster birth-and-death evolution than type II MADS-box genes in angiosperms. Proc Natl Acad Sci U S A 101: 1910-1915.
56. De Bodt S, Raes J, Florquin K, Rombauts S, Rouze P, et al. (2003) Genomewide structural annotation and evolutionary analysis of the type I MADS-box genes in plants. J Mol Evol 56: 573-586.
57. Putnam NH, Srivastava M, Hellsten U, Dirks B, Chapman J, et al. (2007) Sea anemone genome reveals ancestral eumetazoan gene repertoire and genomic organization. Science 317: 86-94.
58. Foltz DR, Jansen L, Bailey AO, Yates JR III, Bassett EA, et al. (2009) Centromere-specific assembly of CENP-a nucleosomes is mediated by HJURP. Cell 137: 472-484.
59. Yang Z, Nielsen R, (2000) Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models. Mol Biol Evol 17: 32-43.
60. Bult CJ, Eppig JT, Kadin JA, Richardson JE, Blake JA, (2008) The Mouse Genome Database (MGD): mouse biology and model systems. Nucleic Acids Research 36: D724.
61. Naya FJ, Black BL, Wu H, Bassel-Duby R, Richardson JA, et al. (2002) Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nature medicine 8: 1303-1309.
62. Lin Q, Schwarz J, Bucana C, (1997) Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276: 1404.
63. Vong L, Bi W, O'Connor-Halligan KE, Li C, Cserjesi P, et al. (2006) MEF2C is required for the normal allocation of cells between the ventricular and sinoatrial precursors of the primary heart field. Developmental Dynamics 235: 1809-1821.
64. Kumar S, Subramanian S, (2002) Mutation rates in mammalian genomes. Proceedings of the National Academy of Sciences of the United States of America 99: 803.
65. Gu X, Li WH, (1992) Higher rates of amino acid substitution in rodents than in humans. Molecular Phylogenetics and Evolution 1: 211-214.
66. Bromham L, (2009) Why do species vary in their rate of molecular evolution? Biology Letters 5: 401-404.
67. Wu CI, Li WH, (1985) Evidence for higher rates of nucleotide substitution in rodents than in man. Proc Natl Acad Sci U S A 82: 1741-1745.
68. Martin AP, Palumbi SR, (1993) Body size, metabolic rate, generation time, and the molecular clock. Proceedings of the National Academy of Sciences of the United States of America 90: 4087.
69. De Bodt S, Raes J, Van de Peer Y, Theissen G, (2003) And then there were many: MADS goes genomic. Trends Plant Sci 8: 475-483.
70. Cooper SJ, Trinklein ND, Nguyen L, Myers RM, (2007) Serum response factor binding sites differ in three human cell types. Genome Res 17: 136-144.
71. Sun Q, Chen G, Streb JW, Long X, Yang Y, et al. (2006) Defining the mammalian CArGome. Genome Res 16: 197-207.
72. Wu WW, Shen X, Tao SH, (2010) Characteristics of the CArG-SRF binding context in mammalian genomes. Mammalian Genome 21: 104-113.
73. Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordheim A, (1998) Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 17: 6289-6299.
74. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2007) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 35: D5-D12.
75. Youn HD, Sun L, Prywes R, Liu JO, (1999) Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 286: 790.
76. Youn HD, Liu JO, (2000) Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 13: 85-94.
77. Wilker PR, Kohyama M, Sandau MM, Albring JC, Nakagawa O, et al. (2008) Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nature immunology 9: 603-612.
78. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Molecular biology and evolution 24: 1596.
79. Stark A, Lin MF, Kheradpour P, Pedersen JS, Parts L, et al. (2007) Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature 450: 219-232.
80. Zhang J, Nielsen R, Yang Z, (2005) Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level. Mol Biol Evol 22: 2472-2479.
81. Kimura M, (1985) The neutral theory of molecular evolution. Cambridge Cambridge University Press.